These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antisecretory and antiulcer properties of prostaglandins. Robert A Compr Ther; 1978 Jul; 4(7):10-3. PubMed ID: 668288 [TBL] [Abstract][Full Text] [Related]
6. Role of prostaglandins in the control of gastric acid secretion. Peskar BM Hepatogastroenterology; 1980 Aug; 27(4):330-6. PubMed ID: 7009357 [No Abstract] [Full Text] [Related]
7. Prostaglandin therapy for peptic ulcer disease. Wilson DE Compr Ther; 1978 Jul; 4(7):44-8. PubMed ID: 668293 [TBL] [Abstract][Full Text] [Related]
9. Development and therapeutic role of synthetic prostaglandins in peptic ulcer disease. Collins PW J Med Chem; 1986 Apr; 29(4):437-43. PubMed ID: 3514911 [No Abstract] [Full Text] [Related]
10. [Prostaglandin analogues in the treatment of peptic ulcer disease]. Laursen LS; Havelund T; Lauritsen K; Madsen JR Ugeskr Laeger; 1989 Jan; 151(2):74-8. PubMed ID: 2643240 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of mucosal defence by prostaglandins. Rationale and clinical experience in ulcer disease. Rask-Madsen J; Lauritsen K Scand J Gastroenterol Suppl; 1987; 128():34-42. PubMed ID: 3306900 [No Abstract] [Full Text] [Related]
12. Prostaglandins: effects on the gastrointestinal tract. Robert A Clin Physiol Biochem; 1984; 2(2-3):61-9. PubMed ID: 6386280 [TBL] [Abstract][Full Text] [Related]
13. Experimental production of peptic ulcer, gastric damage and cancer models and their use in pathophysiological studies and pharmacological treatment--Polish achievements. Brzozowski T J Physiol Pharmacol; 2003 Dec; 54 Suppl 3():99-126. PubMed ID: 15075467 [TBL] [Abstract][Full Text] [Related]
14. [Prostaglandins in ulcer?]. Sewing KF Z Gastroenterol; 1986 May; 24(5):250-1. PubMed ID: 3727653 [No Abstract] [Full Text] [Related]
15. [Clinical aspects of cytoprotection with prostaglandin analogs]. Simon B; Kather H Z Gastroenterol; 1980 Jun; 18(6):320-4. PubMed ID: 7415352 [TBL] [Abstract][Full Text] [Related]
16. [The place and role of prostaglandins in the physiopathology of the stomach]. Andreica V Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(5):411-20. PubMed ID: 6143359 [No Abstract] [Full Text] [Related]
17. Effects of TY-10957, a stable PGI2 derivative, on gastroduodenal lesions and secretory responses in the rat. Okabe S; Takeuchi K; Niida H; Takinami Y Digestion; 1990; 45(2):61-71. PubMed ID: 2112498 [TBL] [Abstract][Full Text] [Related]
18. [Prostaglandins and the gastric mucosa barrier]. Molinari F; Parodi MC Recenti Prog Med; 1982 Oct; 73(4):363-7. PubMed ID: 7156464 [No Abstract] [Full Text] [Related]
19. Effect of prostaglandin E1 on gastric secretion and ulcer formation in the rat. Robert A; Nezamis JE; Phillips JP Gastroenterology; 1968 Oct; 55(4):481-7. PubMed ID: 5698627 [No Abstract] [Full Text] [Related]
20. [Prostaglandin implications at the gastric level]. Nechifor M Rev Med Chir Soc Med Nat Iasi; 1979; 83(4):622; 628; 649-50. PubMed ID: 399062 [No Abstract] [Full Text] [Related] [Next] [New Search]